Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
duac hlaup
stiefel laboratories legacy (ireland) ltd - benzoylis peroxidum; clindamycinum fosfat - hlaup
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
keflex mixtúrukyrni, dreifa 50 mg/ml
stada nordic aps. - cefalexinum mónóhýdrat - mixtúrukyrni, dreifa - 50 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
zovirax krem 50 mg/g
haleon denmark aps - aciclovirum inn - krem - 50 mg/g
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
vaniqa
almirall, s.a. - eflomitín - hirsutism - aðrar húðsjúkdómar - meðferð við andlitshirsutism hjá konum.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
panodil brus freyðitafla 500 mg
haleon denmark aps - paracetamolum inn - freyðitafla - 500 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
soolantra krem 10 mg/g
galderma nordic ab - ivermectinum inn - krem - 10 mg/g
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
opzelura
incyte biosciences distribution b.v. - ruxolitinib phosphate - vitiligo - aðrar húðsjúkdómar - opzelura is indicated for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
ketogan endaþarmsstíll 10 mg + 50 mg
pfizer aps - n.n-dimethyl-4.4-diphenyl-3-butene-2-amine klóríð; cetobemidonum hýdróklóríð - endaþarmsstíll - 10 mg + 50 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
ketogan tafla 5 mg + 25 mg
pfizer aps - n.n-dimethyl-4.4-diphenyl-3-butene-2-amine klóríð; cetobemidonum hýdróklóríð - tafla - 5 mg + 25 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
elvanse adult hart hylki 30 mg
takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 30 mg